Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)

Market Cap	2.41B +15.7%
Revenue (ttm)	252.77M +2.1%
Net Income	39.35M -9.1%
EPS	0.51 -6.2%
Shares Out	76.49M
PE Ratio	61.32
Forward PE	n/a
Dividend	0.26 (0.82%)
Ex-Dividend Date	May 29, 2025

Volume	869,900
Average Volume	1,280,536
Open	31.42
Previous Close	31.66
Day's Range	31.32 - 31.84
52-Week Range	22.83 - 36.98
Beta	0.61
RSI	58.94
Earnings Date	Apr 29, 2026

About SHE:301130

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anemia, mental disorders, anti-psychotic disorders, cardiovascular and cerebrovascular diseases, and tumors. It provides drugs in the form of tablets and capsules. The company was founded in 1990 and is headquartered in Panshi, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 320
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301130

Financial Performance

In 2024, SHE:301130's revenue was 256.41 million, an increase of 13.71% compared to the previous year's 225.49 million. Earnings were 40.27 million, a decrease of -20.26%.